JNCI Journal of the National Cancer Institute
Oxford University Press · US · ISSN 00278874
SJR Q1
What the numbers say
Output rose while average citedness slipped.
Field-weighted citation impact moved from 4.18 to 2.56. Expect lower average citation performance per article than before. Output grew sharply while citation impact fell. If you prioritize citation visibility, weigh this trend in your decision. The share of top-10% cited papers moved from 49.3% to 29.3%. A smaller share of articles now reach the highest cited ranks, so plan dissemination accordingly. Recent titles increasingly carry multicancer · karisma · endoxifen · nrg · folfirinox. If your work matches these emerging terms it may align with recent topical coverage.
Citation metrics
SJR quartile
Q1
SJR score
3.79
Citations / doc (2y)
5.51
h-index
490
Based on the Scopus and OpenAlex citation graphs. We do not provide Clarivate’s JCR Impact Factor.
Output and citation impact
Whether citation performance keeps up as output grows.
PapersField-weighted impact
2018
237
4.18
2019
232
3.92
2020
221
3.79
2021
227
3.97
2022
225
3.10
2023
261
3.78
2024
348
3.06
2025
393
2.56
Topic shift
Share in the last 24 months (2024-09 – 2026-08) versus the previous 24 (2022-09 – 2024-08).
Rising
- Colorectal Cancer Screening and Detection6.0%→9.5%+3.4%pPrevNow
- Cutaneous Melanoma Detection and Management0.0%→3.3%+3.3%pPrevNow
- Chemotherapy-induced cardiotoxicity and mitigation0.0%→3.0%+3.0%pPrevNow
- Pancreatic and Hepatic Oncology Research0.0%→2.7%+2.7%pPrevNow
- Lung Cancer Diagnosis and Treatment0.0%→2.7%+2.7%pPrevNow
Falling
- Genetic factors in colorectal cancer4.4%→0.0%−4.4%pPrevNow
- Cancer Immunotherapy and Biomarkers7.3%→3.5%−3.7%pPrevNow
- Prostate Cancer Treatment and Research2.8%→0.0%−2.8%pPrevNow
- Cancer survivorship and care8.5%→5.9%−2.5%pPrevNow
- Global Cancer Incidence and Screening10.5%→8.0%−2.5%pPrevNow
Terms appearing more often
Wording in recent paper titles that stands out against the journal's own baseline.
multicancerkarismaendoxifennrgfolfirinoxstatesderuxtecansurvivors
Author countries
Last 24 months (2024-09 – 2026-08) against the previous 24 (2022-09 – 2024-08).
- US59.5%→51.8%−7.7%pPrevNow
- GB6.4%→9.9%+3.5%pPrevNow
- CA11.9%→9.2%−2.7%pPrevNow
- FR5.3%→7.4%+2.0%pPrevNow
- CN4.9%→6.1%+1.2%pPrevNow
- NL0.0%→5.7%+5.7%pPrevNow
Top 5 institutions
Top 5 institutions publishing in this journal, 2018 – 2026.
Recently published
20The 20 most recent papers — not the full list.
1
Article2026
RE: Advance care planning impact on caregivers and end-of-life care in advanced cancerXu Dong, X T Wang, Yan Li
Public Health, Environmental and Occupational HealthMedicine
2
Article2026
RE: Deployment to Karshi-Khanabad Air Base, Uzbekistan between 2001 and 2005 and subsequent risk of specific cancers among US service membersChristin B. DeStefano*
DevelopmentSocial Sciences
3
4
Article2026
Aspirin initiation and dose-dependent risk reduction of oral squamous cell carcinoma in areca nut chewersTing-Yu Yang, Jung-Min Yu, Wan‐Ming Chen, Szu‐Yuan Wu, YING-LIN CHEN
PeriodonticsDentistry
5
Article2026
Trends in colorectal cancer mortality among younger versus older adults in 49 countriesHyuna Sung, Kieran Kelly, Chenxi Jiang, Mathieu Laversanne, Rebecca L Siegel, F. Bray, Ahmedin Jemal
OncologyMedicine
6
Article2026
Quantifying the efficacy-effectiveness gap in first line treatment of metastatic melanomaYago Garitaonaindía, A.A. Luczak, Christina H. Ruhlmann, S.K. Petersen, Rasmus Blechingberg Friis, Troels Holz Borch, Louise Mahncke Guldbrandt, Inge Marie Svane, Henrik Schmidt, Lars Bastholt, Eva Ellebæk, Marco Donia*
Molecular BiologyBiochemistry, Genetics and Molecular Biology
7
Article2026
Prognostic dynamics of pathological complete response and ctDNA clearance after neoadjuvant/perioperative immunotherapy in cancer: a reconstructed individual patient analysisYago Garitaonaindía, Sonja Witteveen, Edoardo Dionisio, Anne Weiss, Eva Ellebaek, Christian Rolfo, Mariano Provencio, Christian Blank, Marco Donia
Cancer ResearchBiochemistry, Genetics and Molecular Biology
8
Article2026
ypTNM versus pTNM staging after neoadjuvant therapy in rectal cancerTeppei Miyakawa, J T Lie, Chung-Yuan Hu, Kentaro Ochiai, Ramy Behman, Stephanie Keeling, Qian Shi, Irıs D. Nagtegaal, Richard Goldberg, George J. Chang*
OncologyMedicine
9
Article2026
Re: Lymphocyte count and risk of chronic lymphocytic leukemiaQiaoyi Shen, Xuan Wu, Zhenghe Liu, Ruijie Li
GeneticsMedicine
10
Article2026
Temporal Trends of Subsequent Malignant Neoplasms in Childhood Cancer Survivors and the Impact of Treatment Changes: A DCCSS-LATER StudyAimée S R Westerveld, Helena J H van der Pal, Joyce Wilbers, Andrica C H de Vries, Marloes Louwerens, Maria M W Koopman, Judith L. Kok, Marry M. van den Heuvel‐Eibrink, Margriet van der Heiden - van der Loo, Dorine Bresters, Max M van Noesel, Eelco W. Hoving, Jan L C Loeffen, Hanneke M. van Santen, F Van Leeuwen, Otto Visser, Geert O. Janssens, Cecile M Ronckers, L. C.M. Kremer, Jop C. Teepen*
OAPediatrics, Perinatology and Child HealthMedicine
11
Article2026
Association of common genetic alterations with tumor recurrence in papillary thyroid cancerShi-Tong Yu, Liyuan Huang, Hui Tang, Ruitian Ouyang, Guobin Miao, Nanfen Zhou, Shujing Mao, Jichun Yu, 刘仍允, Shangtong Lei
Endocrinology, Diabetes and MetabolismMedicine
12
Article2026
Modeling long-term mortality and morbidity in pediatric Hodgkin lymphoma survivors after reduced radiotherapy exposureJenna R. Rogers, Zachary J. Ward, Kayla Stratton, Wendy M. Leisenring, Chelsea S Taylor, Gregory T Armstrong, Eric J Chow, Angela M. Feraco, Rebecca M Howell, Melissa M Hudson, Mercedes McMahon, Lindsay M Morton, Kevin C Oeffinger, Susan A Smith, LR Diller, Jennifer M. Yeh
Pathology and Forensic MedicineMedicine
13
Article2026
RE: Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trialX T Wang, Xinyi Xu, Y Li*
Pulmonary and Respiratory MedicineMedicine
14
Article2026
Re: Polygenic risk scores for pre-MRI risk stratification in men with clinically suspected prostate cancerAmit Sud*, Richard S. Houlston
Pulmonary and Respiratory MedicineMedicine
15
Article2026
Sex differences in cancer incidence among people with HIV infection in the United StatesBeth J. Maclin, Ruth M Pfeiffer, Qianlai Luo, Natalie Archer, Jennifer Hayes, Analise Monterosso, Karen Pawlish, A Regalado Ortiz, Meredith S Shiels, E M Engels, Sarah S. Jackson*
OncologyMedicine
16
Article2026
Beyond survival: the risk of subsequent primary melanoma in childhood cancer survivorsLindsay F. Schwartz, Kevin C Oeffinger, Tara O. Henderson*
Pediatrics, Perinatology and Child HealthMedicine
17
Article2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, Kerwin F Shannon, AndrewJ Spillane, Jonathan R. Stretch, Sydney Ch’ng, Omgo E Nieweg, John F Thompson, Michelle M. Dugan, Danielle K. DePalo, Helana Ghali, Jonathan S Zager, Martin Heaton, Andrew Snelling, Iva Johansson, Roger Olofsson Bagge, Carolyn Nessim, Marc Moncrieff
OncologyMedicine
18
Article2026
Liver cancer risk in the context of today’s hormonal contraceptivesLouise Rand, Caroline H Hemmingsen, S K Kjaer, Jasmin Arvedsen, Amani Meaidi, E Dahl, Lina Steinrud Mørch
Public Health, Environmental and Occupational HealthMedicine
19
Article2026
Quantifying the effects of ultraviolet radiation on cutaneous melanoma, 1990—2021, and projecting to 2032Qiqi Xiao, Hao Xiang, Ying Liu, Jiahui Tong, Qi Tang, Kenan Li, Yuchen Li, Rui Zhu, Yi Xu*
OncologyMedicine
20
Article2026
Racial and ethnic differences in opioid fills following cancer-directed surgery among older and younger Medicare beneficiariesAshley Odai-Afotey, X Wang, Nancy L. Keating, Mary Beth Landrum, Alexi A. Wright, Andrea Enzinger*
Public Health, Environmental and Occupational HealthMedicine
Most cited
20Top 20 most cited, 2018 – 2026.
1
ArticleCitations 7332020
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working GroupTorsten O. Nielsen*, Samuel Leung, David L. Rimm, Andrew Dodson, Balázs Ács, Sunil Badve, Carsten Denkert, Matthew J. Ellis, Susan Fineberg, Margaret Flowers, Hans Kreipe, Anne‐Vibeke Lænkholm, Hongchao Pan, Frédérique Penault‐Llorca, Mei‐Yin C. Polley, Roberto Salgado, Ian E. Smith, Tomoharu Sugie, John M.S. Bartlett, Lisa M. McShane, Mitch Dowsett, Daniel F. Hayes
OACancer ResearchBiochemistry, Genetics and Molecular Biology
2
ArticleCitations 6762018
Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 RadiologistsAlejandro Rodríguez‐Ruiz, Kristina Lång, Albert Gubern‐Mérida, Mireille J. M. Broeders, Gisella Gennaro, Paola Clauser, Thomas H. Helbich, Margarita Chevalier, Tao Tan, Thomas Mertelmeier, Matthew Wallis, Ingvar Andersson, Sophia Zackrisson, Ritse M. Mann, Ioannis Sechopoulos*
OAArtificial IntelligenceComputer Science
3
ArticleCitations 5562018
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease StageLauren C. Peres*, Kara L. Cushing‐Haugen, Martin Köbel, Holly R. Harris, Andrew Berchuck, Mary Anne Rossing, Joellen M. Schildkraut, Jennifer A. Doherty
OAReproductive MedicineMedicine
4
ReviewCitations 5262018
Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial ParticipationJoseph M. Unger*, Riha Vaidya, Dawn L. Hershman, Lori M. Minasian, Mark E. Fleury
OAPublic Health, Environmental and Occupational HealthMedicine
5
ReviewCitations 4952018
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and ElaborationWilli Sauerbrei*, Sheila E. Taube, Lisa M. McShane, Margaret M. Cavenagh, Douglas G. Altman
OAStatistics, Probability and UncertaintyDecision Sciences
6
ArticleCitations 4892021
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer StatisticsFarhad Islami*, Elizabeth Ward, Hyuna Sung, Kathleen A. Cronin, Florence K. L. Tangka, Recinda Sherman, Jingxuan Zhao, Robert N. Anderson, S. Jane Henley, K. Robin Yabroff, Ahmedin Jemal, Vicki B. Benard
OAOncologyMedicine
7
ReviewCitations 4312019
Antibody-Drug Conjugate-Based Therapeutics: State of the ScienceMichael J. Birrer*, Kathleen N. Moore, Ilaria Betella, Richard C. Bates
Radiology, Nuclear Medicine and ImagingMedicine
8
ReviewCitations 3962019
Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and PolicyLarissa Nekhlyudov*, Michelle Mollica, Paul B. Jacobsen, Deborah K. Mayer, Lawrence N. Shulman, Ann M. Geiger
OAOncologyMedicine
9
ReviewCitations 3942018
Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic ReviewHelena Carreira*, Rachael Williams, Martín Müller, Rhea Harewood, Susannah Stanway, Krishnan Bhaskaran
OAPulmonary and Respiratory MedicineMedicine
10
ArticleCitations 3932018
An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer ScreeningLiming Hu, D. A. Bell, Sameer Antani, Zhiyun Xue, Kai Yu, Matthew P. Horning, Noni Gachuhi, Benjamin Wilson, Mayoore S. Jaiswal, Brian Befano, L. Rodney Long, Rolando Herrero, Mark H. Einstein, Robert D. Burk, Maria Demarco, Julia C. Gage, Ana Cecilia Rodríguez, Nicolas Wentzensen, Mark Schiffman*
OAEpidemiologyMedicine
11
ArticleCitations 3572018
Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the NetherlandsJohanna M. Meulepas, Cécile M. Ronckers, Anne Smets, Rutger A. J. Nievelstein, Patrycja Gradowska, Choonsik Lee, Andréas Jahnen, Marcel van Straten, Marie‐Claire Y. de Wit, Bernard A. Zonnenberg, Willemijn M. Klein, Johannes H. M. Merks, Otto Visser, Flora E. van Leeuwen, Michael Hauptmann*
OARadiology, Nuclear Medicine and ImagingMedicine
12
ArticleCitations 3472021
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary DiagnosisRikke Nørgaard Pedersen, Buket Öztürk, Lene Mellemkjær, Peer Christiansen, Bent Ejlertsen, Timothy L. Lash, Mette Nørgaard, Deirdre Cronin‐Fenton*
OACancer ResearchBiochemistry, Genetics and Molecular Biology
13
ArticleCitations 3382021
Therapy-Induced Senescence: Opportunities to Improve Anticancer TherapyPataje G.S. Prasanna*, Deborah E. Citrin, Jeffrey Hildesheim, Mansoor M. Ahmed, Sundar Venkatachalam, Gabriela Riscuta, Dan Xi, Guangrong Zheng, Jan van Deursen, Jörg J. Goronzy, Stephen J. Kron, Mitchell S. Anscher, Norman E. Sharpless, Judith Campisi, Stephen L. Brown, Laura J. Niedernhofer, Ana O’Loghlen, Alexandros G. Georgakilas, François Paris, David Gius, David A. Gewirtz, Clemens A. Schmitt, Mohamed E. Abazeed, James L. Kirkland, Ann Richmond, Paul B. Romesser, Scott W. Lowe, Jesús Gil, Marc S. Mendonca, Sandeep Burma, Daohong Zhou, C. Norman Coleman
OAPhysiologyMedicine
14
ReviewCitations 3292018
Biomarkers for Homologous Recombination Deficiency in CancerMichał Marek Hoppe, Raghav Sundar, David S.P. Tan*, Anand D. Jeyasekharan*
OAOncologyMedicine
15
ArticleCitations 3252019
Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20–49 YearsElizabeth Ward, Recinda Sherman*, S. Jane Henley, Ahmedin Jemal, David A. Siegel, Eric J. Feuer, Albert U. Firth, Betsy Kohler, Susan Scott, Jiemin Ma, Robert N. Anderson, Vicki B. Benard, Kathleen A. Cronin
OAEpidemiologyMedicine
16
ArticleCitations 3222019
Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001–2015Ashish A. Deshmukh*, Ryan Suk, Meredith S. Shiels, Kalyani Sonawane, Alan G. Nyitray, Yuxin Liu, Michael Gaisa, Joel M. Palefsky, Keith Sigel
OASurgeryMedicine
17
ArticleCitations 3182018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, Steven N. Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M. Moore, Hiltrud Brauch, Angela Cox, Diana Eccles, Amanda E. Toland, Peter A. Fasching, Florentia Fostira, Judy E. Garber, Andrew K. Godwin, Irene Konstantopoulou, Heli Nevanlinna, Priyanka Sharma, Drakoulis Yannoukakos, Song Yao, Bing Feng, Brigette Tippin Davis, Jenna Lilyquist, Tina Pesaran, David E. Goldgar, Eric C. Polley, Jill S. Dolinsky, Fergus J. Couch*
OAGeneticsBiochemistry, Genetics and Molecular Biology
18
ArticleCitations 3062021
Atezolizumab and <i>nab</i>-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 StudyLeisha A. Emens*, Luciana Molinero, Sherene Loi, Hope S. Rugo, Andreas Schneeweiß, Véronique Dièras, Hiroji Iwata, Carlos H. Barrios, M. Nechaeva, Anh Nguyen‐Duc, Jane Yuet Ching Hui, Amreen Husain, Eric P. Winer, Sylvia Adams, Peter Schmid
OAOncologyMedicine
19
ArticleCitations 2972021
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical CancerSusanne K. Kjær, Christian Dehlendorff, F. Belmonte, Louise Baandrup*
OAEpidemiologyMedicine
20
ReviewCitations 2952019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P. Janssen, Stefan Buettner, Mustafa Suker, Berend R. Beumer, Pietro Addeo, Philippe Bachellier, Nathan Bahary, Tanios Bekaii‐Saab, Maria Antonietta Bali, Marc G. Besselink, Brian A. Boone, Ian Chau, Stephen Clarke, Mary Dillhoff, Bassel F. El‐Rayes, Jessica M. Frakes, Derek Grose, Peter J. Hosein, Nigel B. Jamieson, Ammar A. Javed, Khurum Khan, Kyu-pyo Kim, Song Cheol Kim, Sunhee S. Kim, Andrew H. Ko, Jill Lacy, Georgios Antonios Margonis, Martin D. McCarter, Colin J. McKay, Eric A. Mellon, Sing Yu Moorcraft, Ken‐ichi Okada, Alessandro Paniccia, Parag J. Parikh, Niek A. Peters, Hans Rabl, Jaswinder S. Samra, Christoph Tinchon, Geertjan van Tienhoven, Eran van Veldhuisen, Andrea Wang‐Gillam, Matthew J. Weiss, Johanna W. Wilmink, Hiroki Yamaue, Marjolein Y.V. Homs, Casper H.J. van Eijck, Matthew H. G. Katz, Bas Groot Koerkamp*
OAOncologyMedicine
Similar journals
Check your draft against this journal
Start free with Nubint AI — citation checks and a peer-review simulation.
Data as of 2026-09-05